T-Y Tsai1, C-Y Kuo2, Y-C Huang1,3. 1. Department of Dermatology, Wan Fang Hospital, Taipei Medical University, Taipei, Taiwan. 2. Department of Ophthalmology, Taipei Veterans General Hospital, Taipei, Taiwan. 3. Department of Dermatology, School of Medicine, College of Medicine, Taipei Medical University, Taipei, Taiwan.
Abstract
BACKGROUND: Vitamin D has antineoplastic effects, but the synthesis of vitamin D requires ultraviolet radiation, a known risk factor for melanoma. OBJECTIVE: To investigate the correlations between serum vitamin D levels and risk and prognosis of melanoma. METHODS: A systematic review and meta-analysis were conducted. Online databases were searched on 31 Oct 2018. RESULTS: Twenty-five studies with a total of 11166 patients with melanoma were included. There was no significant difference in serum vitamin D levels between patients with melanoma and controls [standardized mean difference (SMD), -0.185; 95% confidence interval (CI), -0.533 to 0.162]. However, the prevalence of vitamin D deficiency was significantly higher in patients with melanoma than that in controls (odds ratio, 2.115; 95% CI, 1.151-3.885). In terms of prognosis, serum vitamin D levels were significantly higher in melanoma patients with lower Breslow thickness (≦1 vs. >1 mm: SMD, 0.243; 95% CI, 0.160-0.327). Moreover, melanoma patients with lower vitamin D levels had a significantly higher mortality rate (hazard ratio, 1.558; 95% CI, 1.258-1.931). CONCLUSIONS: Vitamin D deficiency is associated with higher Breslow thickness and mortality in melanoma patients.
BACKGROUND:Vitamin D has antineoplastic effects, but the synthesis of vitamin D requires ultraviolet radiation, a known risk factor for melanoma. OBJECTIVE: To investigate the correlations between serum vitamin D levels and risk and prognosis of melanoma. METHODS: A systematic review and meta-analysis were conducted. Online databases were searched on 31 Oct 2018. RESULTS: Twenty-five studies with a total of 11166 patients with melanoma were included. There was no significant difference in serum vitamin D levels between patients with melanoma and controls [standardized mean difference (SMD), -0.185; 95% confidence interval (CI), -0.533 to 0.162]. However, the prevalence of vitamin D deficiency was significantly higher in patients with melanoma than that in controls (odds ratio, 2.115; 95% CI, 1.151-3.885). In terms of prognosis, serum vitamin D levels were significantly higher in melanomapatients with lower Breslow thickness (≦1 vs. >1 mm: SMD, 0.243; 95% CI, 0.160-0.327). Moreover, melanomapatients with lower vitamin D levels had a significantly higher mortality rate (hazard ratio, 1.558; 95% CI, 1.258-1.931). CONCLUSIONS:Vitamin D deficiency is associated with higher Breslow thickness and mortality in melanomapatients.
Authors: M Lombardo; A Vigezzi; G Ietto; C Franchi; V Iori; F Masci; A Scorza; S Macchi; D Iovino; C Parise; G Carcano Journal: Sci Rep Date: 2021-03-12 Impact factor: 4.379
Authors: Anna Piotrowska; Fernando Pereira Beserra; Justyna Marta Wierzbicka; Joanna Irena Nowak; Michał Aleksander Żmijewski Journal: Front Oncol Date: 2021-12-24 Impact factor: 6.244
Authors: Casey R Johnson; Daniel V Dudenkov; Kristin C Mara; Philip R Fischer; Julie A Maxson; Tom D Thacher Journal: Mayo Clin Proc Date: 2021-08 Impact factor: 11.104
Authors: Jo S Stenehjem; Nathalie C Støer; Reza Ghiasvand; Tom K Grimsrud; Ronnie Babigumira; Judy R Rees; Lill Tove Nilsen; Bjørn Johnsen; Per M Thorsby; Marit B Veierød; Trude E Robsahm Journal: Sci Rep Date: 2020-11-18 Impact factor: 4.379